Wim Terryn

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

Marieke Biegstraaten, Reynir Arngrı́msson, Frédéric Barbey et al. · Orphanet Journal of Rare Diseases · 2015 · 335 citations · Full text

Screening, diagnosis, and management of patients with Fabry disease: conclusions from a “Kidney Disease: Improving Global Outcomes” (KDIGO) Controversies Conference

Raphael Schiffmann, Derralynn Hughes, Gabor E. Linthorst et al. · Kidney International · 2016 · 175 citations

IRF2BPL Is Associated with Neurological Phenotypes

Paul C. Marcogliese, Vandana Shashi, Rebecca C. Spillmann et al. · The American Journal of Human Genetics · 2018 · 108 citations · Full text

Neurology, Neuroscience, Molecular Neurobiology +4

Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice

Wim Terryn, Pierre Cochat, Roseline Froissart et al. · Nephrology Dialysis Transplantation · 2012 · 106 citations · Full text

Glomerular Disease, Renal Pathology, Pathology +23

Chronic kidney disease and an uncertain diagnosis of Fabry disease: Approach to a correct diagnosis

Linda van der Tol, Einar Svarstad, Alberto Ortíz et al. · Molecular Genetics and Metabolism · 2014 · 63 citations

Glomerular Disease, Glomerulonephritis, Hemodialysis +12